Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.
Publication
, Journal Article
Halpern, AB; Lyman, GH; Walsh, TJ; Kontoyiannis, DP; Walter, RB
Published in: Blood
December 24, 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
December 24, 2015
Volume
126
Issue
26
Start / End Page
2790 / 2797
Location
United States
Related Subject Headings
- Mycoses
- Middle Aged
- Male
- Leukemia, Myeloid, Acute
- Immunology
- Immunocompromised Host
- Humans
- Antifungal Agents
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Halpern, A. B., Lyman, G. H., Walsh, T. J., Kontoyiannis, D. P., & Walter, R. B. (2015). Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood, 126(26), 2790–2797. https://doi.org/10.1182/blood-2015-07-627323
Halpern, Anna B., Gary H. Lyman, Thomas J. Walsh, Dimitrios P. Kontoyiannis, and Roland B. Walter. “Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.” Blood 126, no. 26 (December 24, 2015): 2790–97. https://doi.org/10.1182/blood-2015-07-627323.
Halpern AB, Lyman GH, Walsh TJ, Kontoyiannis DP, Walter RB. Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood. 2015 Dec 24;126(26):2790–7.
Halpern, Anna B., et al. “Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.” Blood, vol. 126, no. 26, Dec. 2015, pp. 2790–97. Pubmed, doi:10.1182/blood-2015-07-627323.
Halpern AB, Lyman GH, Walsh TJ, Kontoyiannis DP, Walter RB. Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood. 2015 Dec 24;126(26):2790–2797.
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
December 24, 2015
Volume
126
Issue
26
Start / End Page
2790 / 2797
Location
United States
Related Subject Headings
- Mycoses
- Middle Aged
- Male
- Leukemia, Myeloid, Acute
- Immunology
- Immunocompromised Host
- Humans
- Antifungal Agents
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology